Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 29, 2025 08:00 ET | Source: Therini Bio, Inc.

Therini Bio Announces First Patient Dosed in Phase 1b Trial of THN391 in Alzheimer’s Disease

Therini Bio announced the dosing of the first patient in their Phase 1b trial evaluating THN391 in Alzheimer's Disease
May 14, 2025 10:00 ET | Source: Therini Bio, Inc.

Therini Bio Raises Additional $39M Series A Financing to Advance Clinical Development of Neurodegenerative Disease Pipeline

Therini Bio raised a $39M Series A financing, bringing the Series A total to $75M, from top-tier investors to commence THN391 Ph 1b AD and DME studies
April 29, 2025 10:00 ET | Source: Therini Bio, Inc.

Therini Bio Announces Positive Phase 1a Trial Results Evaluating THN391 for Neurodegenerative Diseases

Therini Bio's novel approach to treating neurodegenerative diseases yielded positive results in a Phase 1a study evaluating its lead candidate, THN391.
December 09, 2024 07:30 ET | Source: FACT.MR

Tissue Glue and Bio-Adhesive Sealant Market to Reach US$ 4.91 Billion by 2034, Growing at 8% CAGR | Fact.MR Report

Rockville, MD, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Tissue glue and bio-adhesive sealants effectively seal skin wounds and lacerations, which has been driving their increasing popularity worldwide. The...
May 08, 2024 09:00 ET | Source: Therini Bio, Inc.

Therini Bio Announces Positive Preclinical Data Supporting the Development of THN391 in Neurodegenerative Ocular Diseases

THN391, a mAb designed to block neuroinflammation triggered by fibrin, demonstrated effectiveness in protecting against vascular and neuronal degeneration
March 27, 2023 04:48 ET | Source: Research and Markets

Fibrin Sealants Global Market to Reach $2.6 Billion by 2031: Surge in the Prevalence of Chronic Diseases Fuels the Sector

Dublin, March 27, 2023 (GLOBE NEWSWIRE) -- The "Fibrin Sealants Market By Dosage Forms, By Application, By End User: Global Opportunity Analysis and Industry Forecast, 2021-2031" report has been...
September 09, 2022 07:33 ET | Source: Research and Markets

Global Bleeding Disorders Treatment Market Report 2022: Increased Focus of Pharmaceutical Companies on Recombinant Products Creates Opportunities

Dublin, Sept. 09, 2022 (GLOBE NEWSWIRE) -- The "Global Bleeding Disorders Treatment Market By Drug Type, By Disease Type, By Distribution Channel, By End User By Region, Competition, Forecast &...